Literature DB >> 1701357

Up-regulation of transferrin receptor gene expression by granulocyte colony-stimulating factor in human myeloid leukemia cells.

Y Morishita1, T Kataoka, M Towatari, T Ito, H Inoue, M Ogura, Y Morishima, H Saito.   

Abstract

Granulocyte colony-stimulating factor (G-CSF) enhanced surface transferrin receptor (TfR) expression in two human myeloid leukemia cell lines, NKM-1 and NOMO-1, which possess G-CSF receptors. Radioligand-binding assay revealed that 10 ng/ml G-CSF significantly increased TfR to 186 +/- 20 and 276 +/- 38% of control for NKM-1 cells and NOMO-1 cells, respectively, in a 24-h culture. Scatchard analysis showed the increase of transferrin (Tf)-binding sites but no change in the receptor affinity. The enhanced TfR expression was not mediated either by the kinetic change of receptor cycling or by cellular iron content. Immunoprecipitation with anti-TfR antibody was used, and the increased biosynthesis of the receptor was demonstrated in G-CSF-stimulated cells. Northern blot analysis showed a 2- to 3-fold increase of TfR mRNA of NKM-1 cells cultured in medium containing Tf and G-CSF, whereas the mRNA declined without G-CSF. The effect of G-CSF on the TfR mRNA was observed within 2 h, which preceded the increase of surface TfR and the transition to the S phase of the cell cycle. G-CSF also potentiated TfR expression in freshly obtained myeloid leukemia cells. The present study shows up-regulation of TfR expression by G-CSF in myeloid leukemia cells and provides evidence that the regulation is mediated by controlling the steady-state level of the mRNA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701357

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma.

Authors:  R Suzuki; K Takemura; M Tsutsumi; S Nakamura; N Hamajima; M Seto
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

2.  Induction of junB expression, but not c-jun, by granulocyte colony-stimulating factor or macrophage colony-stimulating factor in the proliferative response of human myeloid leukemia cells.

Authors:  K Adachi; H Saito
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

3.  Fibroblast Growth Factor-2 facilitates the growth and chemo-resistance of leukemia cells in the bone marrow by modulating osteoblast functions.

Authors:  Keiki Sugimoto; Yasuhiko Miyata; Takayuki Nakayama; Shigeki Saito; Ritsuro Suzuki; Fumihiko Hayakawa; Satoshi Nishiwaki; Hiroki Mizuno; Kyosuke Takeshita; Hidefumi Kato; Ryuzo Ueda; Akiyoshi Takami; Tomoki Naoe
Journal:  Sci Rep       Date:  2016-08-02       Impact factor: 4.379

4.  The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia.

Authors:  Mehdi Ghasemi; Mufide Okay; Seyhan Turk; Ronak Naeemaee; Ebru Guver; Umit Y Malkan; Salih Aksu; Nilgun Sayinalp; Ibrahim C Haznedaroglu
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2019 Apr-Jun       Impact factor: 1.636

Review 5.  Iron Metabolism in the Tumor Microenvironment: Contributions of Innate Immune Cells.

Authors:  Wei Liang; Napoleone Ferrara
Journal:  Front Immunol       Date:  2021-02-12       Impact factor: 7.561

6.  DNA-double strand breaks enhance the expression of major histocompatibility complex class II through the ATM-NF-κΒ-IRF1-CIITA pathway.

Authors:  Tsukasa Oda; Ruri Nakamura; Tetsuhiro Kasamatsu; Nanami Gotoh; Keiko Okuda; Takayuki Saitoh; Hiroshi Handa; Hirokazu Murakami; Takayuki Yamashita
Journal:  Cancer Gene Ther       Date:  2021-02-22       Impact factor: 5.987

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.